Bank of New York Mellon
ARMP icon

Bank of New York Mellon’s Armata Pharmaceuticals ARMP Stock Holding History

Bank of New York Mellon’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
+29,749
New +$273K ﹤0.01% 4152
2017
Q2 		– Sell
-84
Closed -$5K – 4296
2017
Q1 		$5K Buy
+84
New +$5.71K ﹤0.01% 4268

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon's ARMP Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 29,749 shares worth $193K. The stake represents ﹤0.01% of the portfolio and ranks #4152 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in ARMP as recently as Q1 2017.

Bank of New York Mellon first reported a position in ARMP in Q1 2017 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Bank of New York Mellon held 29,749 shares of Armata Pharmaceuticals worth $193K as of Q2 2026.
  • Armata Pharmaceuticals was a new Bank of New York Mellon position in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4152 holding.
  • Bank of New York Mellon first reported a position in Armata Pharmaceuticals in Q1 2017 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.